Sfoglia per Rivista
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
2016-01-01 Eslam, Mohammed; Mangia, Alessandra; Berg, Thomas; Chan, Henry Lik Yuen; Irving, William L.; Dore, Gregory J.; Abate, Maria Lorena; Bugianesi, Elisabetta; Adams, Leon A.; Najim, Mustafa A.M.; Miele, Luca; Weltman, Martin; Mollison, Lindsay; Cheng, Wendy; Riordan, Stephen; Fischer, Janett; Romero-Gomez, Manuel; Spengler, Ulrich; Nattermann, Jacob; Rahme, Antony; Sheridan, David; Booth, David R.; Mcleod, Duncan; Powell, Elizabeth; Liddle, Christopher; Douglas, Mark W.; van der Poorten, David; George, Jacob; White, Rose; Rojas, Angela; Gallego-Duran, Rocio; Bassendine, Margaret; Wong, Vincent W.S.; Rosso, Chiara; Mezzabotta, Lavinia; Leung, Reynold; Malik, Barbara; Matthews, Gail; Applegate, Tanya; Grebely, Jason; Fragomeli, Vincenzo; Jonsson, Julie R.; Santaro, Rosanna
Does nonalcoholic steatohepatitis (NASH) progress to cryptogenic cirrhosis (CC) and hepatocellular carcinoma (HCC) - A case-control study.
2001-01-01 N. Leone; E. Bugianesi; F. Brunello; P. Carucci; E. Vanni; G.M. Reggiani; A. Musso; A. Muratore; P. De Paolis; L. Capussotti; M. Salizzoni; M.
Effect of the cannabinoid CB1 receptor antagonist SR 141716 in a rat model of liver inflammation
2004-01-01 CARACENI P; PERTOSA A.M; DOMENICALI M; CAVALIERI B; PERRELLI M-G; PRINCIPE A; CUTRÌN J.C; CROCI T
Effects of Candoxatrilat, a neutral endopeptidase inhibitor, on sodium and free water urinary excretion in the rat model of CCl4-induced cirrhosis with ascites.
2003-01-01 Sansoé G; Aragno M; Mastrocola R; Restivo F; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M.
Effects of systemic prostaglandin E1 on hepatic amino acid-nitrogen metabolism in patients with cirrhosis.
1998-01-01 FABBRI A; BIANCHI G; BRIZI M; E. BUGIANESI; MAGALOTTI D; ZOLI M; MARCHESINI G
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
1995-01-01 TODROS L ;SARACCO G ;DURAZZO M ;ABATE ML ;TOUSCOZ G ;SCAGLIONE L ;VERME G ;RIZZETTO M
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
2014-01-01 Irene Locatelli;Salvatore Sutti;Aastha Jindal;Marco Vacchiano;Cristina Bozzola;Chris Reutelingsperger;Dennis Kusters;Stefania Bena;Maurizio Parola;Claudia Paternostro;Elisabetta Bugianesi;Simon McArthur;Emanuele Albano;Mauro Perretti
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
2005-01-01 N. Villanova;S. Moscatiello;S. Ramilli;E. Bugianesi;D. Magalotti;E. Vanni;M. Zoli;G. Marchesini
Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis
1997-01-01 ROLLA G; BRUSSINO L; COLAGRANDE P; DUTTO L; POLIZZI S; SCAPPATICCI E; BERGERONE S; MORELLO M; MARZANO A; MARTINASSO G; SALIZZONI M; C. BUCCA
Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen.
1981-01-01 Rizzetto M; Canese MG; Purcell RH; London WT; Sly LD; Gerin JL.
Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus
1994-01-01 TAPPERO G ;NATOLI G ;ANFOSSI G ;ROSINA F ;NEGRO F ;SMEDILE A ;BONINO F ;ANGELI A ;PURCELL RH ;RIZZETTO M
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication
2017-01-01 Martini, Silvia; Salizzoni, Mauro; David, Ezio; Tandoi, Francesco; Fonio, Paolo; Delsedime, Luisa; Strona, Silvia; Dell Olio, Dominic; Saracco, Giorgio Maria; Romagnoli, Renato
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis
2006-01-01 E. BUGIANESI; G. MARCHESINI; E. GENTILCORE; I.H.Y. CUA; E. VANNI; M. RIZZETTO; J. GEORGE
Free-water retention occurs in experimental preascitic liver cirrosi and is influenced by extracellular calcium.
2010-01-01 Sansoé G; Aragno M; Mastrocola R; Parola M
Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
2019-01-01 Younossi, Zobair; Tacke, Frank; Arrese, Marco; Sharma, Barjesh Chander; Mostafa, Ibrahim; Bugianesi, Elisabetta; Wong, Vincent Wai-Sun; Yilmaz, Yusuf; George, Jacob; Fan, Jiangao; Vos, Miriam B
Glucokinase links krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in non-alcoholic fatty liver disease.
2012-01-01 Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL.
HBV cccDNA evaluation in HBV-core antibody (HBcAb)-positive liver transplant donors
2015-01-01 Caviglia, Gp; Tandoi, F; Abate, Ml; Ciancio, A; Romagnoli, R; Smedile, A
Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage.
2000-01-01 DEFRANCESCHI L; FATTOVICH G; F. TURRINI; AYI K; BRUGNARA C; MANZATO F; NOVENTA F; STANZIAL AM; SOLERO P; CORROCHER R
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
2013-01-01 van der Poorten D;Samer CF;Ramezani-Moghadam M;Coulter S;Kacevska M;Schrijnders D;Wu LE;McLeod D;Bugianesi E;Komuta M;Roskams T;Liddle C;Hebbard L;George J
Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease
2016-01-01 Rosso, C.; Kazankov, K.; Marietti, M.; Gaggini, M.; Buzzigoli, E.; Møller, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; Gastaldelli, A.; George, J.; Grønbæk, H.; Bugianesi, E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes | 2016 | Eslam, Mohammed; Mangia, Alessandra; Berg, Thomas; Chan, Henry Lik Yuen; Irving, William L.; Dore, Gregory J.; Abate, Maria Lorena; Bugianesi, Elisabetta; Adams, Leon A.; Najim, Mustafa A.M.; Miele, Luca; Weltman, Martin; Mollison, Lindsay; Cheng, Wendy; Riordan, Stephen; Fischer, Janett; Romero-Gomez, Manuel; Spengler, Ulrich; Nattermann, Jacob; Rahme, Antony; Sheridan, David; Booth, David R.; Mcleod, Duncan; Powell, Elizabeth; Liddle, Christopher; Douglas, Mark W.; van der Poorten, David; George, Jacob; White, Rose; Rojas, Angela; Gallego-Duran, Rocio; Bassendine, Margaret; Wong, Vincent W.S.; Rosso, Chiara; Mezzabotta, Lavinia; Leung, Reynold; Malik, Barbara; Matthews, Gail; Applegate, Tanya; Grebely, Jason; Fragomeli, Vincenzo; Jonsson, Julie R.; Santaro, Rosanna | |
| Does nonalcoholic steatohepatitis (NASH) progress to cryptogenic cirrhosis (CC) and hepatocellular carcinoma (HCC) - A case-control study. | 2001 | N. Leone; E. Bugianesi; F. Brunello; P. Carucci; E. Vanni; G.M. Reggiani; A. Musso; A. Muratore; P. De Paolis; L. Capussotti; M. Salizzoni; M. | |
| Effect of the cannabinoid CB1 receptor antagonist SR 141716 in a rat model of liver inflammation | 2004 | CARACENI P; PERTOSA A.M; DOMENICALI M; CAVALIERI B; PERRELLI M-G; PRINCIPE A; CUTRÌN J.C; CROCI T | |
| Effects of Candoxatrilat, a neutral endopeptidase inhibitor, on sodium and free water urinary excretion in the rat model of CCl4-induced cirrhosis with ascites. | 2003 | Sansoé G; Aragno M; Mastrocola R; Restivo F; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M. | |
| Effects of systemic prostaglandin E1 on hepatic amino acid-nitrogen metabolism in patients with cirrhosis. | 1998 | FABBRI A; BIANCHI G; BRIZI M; E. BUGIANESI; MAGALOTTI D; ZOLI M; MARCHESINI G | |
| Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. | 1995 | TODROS L ;SARACCO G ;DURAZZO M ;ABATE ML ;TOUSCOZ G ;SCAGLIONE L ;VERME G ;RIZZETTO M | |
| Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice | 2014 | Irene Locatelli;Salvatore Sutti;Aastha Jindal;Marco Vacchiano;Cristina Bozzola;Chris Reutelingsperger;Dennis Kusters;Stefania Bena;Maurizio Parola;Claudia Paternostro;Elisabetta Bugianesi;Simon McArthur;Emanuele Albano;Mauro Perretti | |
| Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease | 2005 | N. Villanova;S. Moscatiello;S. Ramilli;E. Bugianesi;D. Magalotti;E. Vanni;M. Zoli;G. Marchesini | |
| Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis | 1997 | ROLLA G; BRUSSINO L; COLAGRANDE P; DUTTO L; POLIZZI S; SCAPPATICCI E; BERGERONE S; MORELLO M; MARZANO A; MARTINASSO G; SALIZZONI M; C. BUCCA | |
| Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen. | 1981 | Rizzetto M; Canese MG; Purcell RH; London WT; Sly LD; Gerin JL. | |
| Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus | 1994 | TAPPERO G ;NATOLI G ;ANFOSSI G ;ROSINA F ;NEGRO F ;SMEDILE A ;BONINO F ;ANGELI A ;PURCELL RH ;RIZZETTO M | |
| Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication | 2017 | Martini, Silvia; Salizzoni, Mauro; David, Ezio; Tandoi, Francesco; Fonio, Paolo; Delsedime, Luisa; Strona, Silvia; Dell Olio, Dominic; Saracco, Giorgio Maria; Romagnoli, Renato | |
| Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis | 2006 | E. BUGIANESI; G. MARCHESINI; E. GENTILCORE; I.H.Y. CUA; E. VANNI; M. RIZZETTO; J. GEORGE | |
| Free-water retention occurs in experimental preascitic liver cirrosi and is influenced by extracellular calcium. | 2010 | Sansoé G; Aragno M; Mastrocola R; Parola M | |
| Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis | 2019 | Younossi, Zobair; Tacke, Frank; Arrese, Marco; Sharma, Barjesh Chander; Mostafa, Ibrahim; Bugianesi, Elisabetta; Wong, Vincent Wai-Sun; Yilmaz, Yusuf; George, Jacob; Fan, Jiangao; Vos, Miriam B | |
| Glucokinase links krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in non-alcoholic fatty liver disease. | 2012 | Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL. | |
| HBV cccDNA evaluation in HBV-core antibody (HBcAb)-positive liver transplant donors | 2015 | Caviglia, Gp; Tandoi, F; Abate, Ml; Ciancio, A; Romagnoli, R; Smedile, A | |
| Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. | 2000 | DEFRANCESCHI L; FATTOVICH G; F. TURRINI; AYI K; BRUGNARA C; MANZATO F; NOVENTA F; STANZIAL AM; SOLERO P; CORROCHER R | |
| Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause? | 2013 | van der Poorten D;Samer CF;Ramezani-Moghadam M;Coulter S;Kacevska M;Schrijnders D;Wu LE;McLeod D;Bugianesi E;Komuta M;Roskams T;Liddle C;Hebbard L;George J | |
| Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease | 2016 | Rosso, C.; Kazankov, K.; Marietti, M.; Gaggini, M.; Buzzigoli, E.; Møller, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; Gastaldelli, A.; George, J.; Grønbæk, H.; Bugianesi, E. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile